TruAlt Bioenergy Q3FY26: Strong Revenue Growth Continues with Strategic Expansion
TruAlt Bioenergy delivered strong Q3FY26 performance with consolidated revenue growing 72% to ₹7.13 billion, though net profit declined 8% to ₹691.90 million due to margin compression from expansion activities. The company made strategic progress with leadership appointment of Monu Kumar as Company Secretary and announced partnership with Honeywell for sustainable aviation fuel facility with 80,000 tonnes annual capacity.

*this image is generated using AI for illustrative purposes only.
TruAlt Bioenergy Limited has delivered robust financial performance for Q3FY26 ended December 31, 2025, showcasing strong revenue momentum alongside strategic business expansion initiatives. The bioenergy company's latest results demonstrate continued operational scaling while navigating seasonal business dynamics.
Financial Performance Overview
The company's Q3FY26 results highlight impressive revenue growth with consolidated performance showing significant year-over-year improvements across key operational metrics.
| Metric: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Consolidated Revenue: | ₹7,132.38 million | ₹4,151.14 million | +71.84% |
| Consolidated Net Profit: | ₹691.90 million | ₹751.92 million | -7.98% |
| EBITDA: | ₹1,314.89 million | ₹1,240.49 million | +6.00% |
| EBITDA Margin: | 18.44% | 29.89% | -1145 bps |
| Basic EPS: | ₹8.07 | ₹10.65 | -24.22% |
Revenue Growth and Operational Expansion
TruAlt Bioenergy's consolidated revenue reached ₹7,132.38 million in Q3FY26, representing substantial growth from ₹4,151.14 million in the corresponding quarter of the previous year. This revenue increase of approximately 72% reflects the company's successful operational expansion and enhanced capacity utilization following the completion of its IPO and subsequent business scaling initiatives.
Profitability and Margin Analysis
Despite strong revenue performance, consolidated net profit declined to ₹691.90 million from ₹751.92 million year-over-year. The company's EBITDA grew modestly to ₹1,314.89 million, though EBITDA margins compressed significantly to 18.44% from 29.89% in the previous year, indicating higher operational costs associated with business expansion activities.
Strategic Business Developments
The company has undertaken several significant strategic initiatives during the quarter. TruAlt Bioenergy appointed Mr. Monu Kumar as Company Secretary and Compliance Officer, bringing over 11 years of experience in corporate governance and regulatory compliance. Additionally, the company entered into a strategic agreement with Honeywell on January 28, 2026, to deploy Ethanol-to-Jet (ETJ) process technology for developing a sustainable aviation fuel production facility with an envisaged capacity of approximately 80,000 tonnes per annum.
IPO Proceeds Utilization and Joint Venture Progress
Following its successful IPO listing in October 2025, the company has utilized ₹519.37 million of the ₹750 million raised, primarily toward capital expenditure and working capital requirements. The company has also progressed its joint venture with Sumitomo Corporation for compressed biogas plants, with construction commenced at three sites expected to be commissioned in the second quarter of calendar year 2027.
Business Outlook and Operational Context
The company's ethanol business continues to exhibit seasonal patterns aligned with sugarcane harvesting cycles. During the quarter, operations were primarily restricted to Unit 3 while conversion activities for dual-feed capability were in progress at Units 1, 2, and 4. Unit 1 became operational in November 2025, with capacity utilization expected to normalize as operational efficiency improvements are implemented across all facilities.






























